Clinical Trials Logo

Clinical Trial Summary

Randomized, double-blind, placebo controlled trial of a combined intervention of zinc, albendazole, and multiple micronutrients in improving environmental enteropathy in Malawian children.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02253095
Study type Interventional
Source Washington University School of Medicine
Contact
Status Completed
Phase N/A
Start date October 2014
Completion date April 2015

See also
  Status Clinical Trial Phase
Completed NCT01832636 - Intervention and Mechanisms of Alanyl-Glutamine for Inflammation, Nutrition, and Enteropathy Phase 3
Active, not recruiting NCT04565821 - Feasibility Study to Assess a Trans-nasal Intestinal Potential Difference Probe N/A
Completed NCT01593033 - Effectiveness of Micronutrient Supplementation and Fish Oil + Micronutrient Supplementation in the Treatment of Environmental Enteropathy N/A
Active, not recruiting NCT03713502 - Enteropathy and Diabetes in HIV Patients
Not yet recruiting NCT05608928 - Ability of the Probiotic Vivomixx to Improve Environmental Enteropathy in Pregnant Women: a Proof of Concept Trial in Bangladesh, Pakistan, Senegal and Zambia Phase 2
Completed NCT02472301 - The Impact of Legumes vs Corn-soy Flour on Environmental Enteric Dysfunction in Rural Malawian Children 1-3 Year Olds N/A